Medco's decision to buy DNA Direct signals its intent to be a "one-stop shop" for payors and employers interested in using genetically guided medicine to make healthcare more efficient and lower costs.
Danaher has closed the acquisition, and the mass spec operations will operate under the name AB Sciex. MDS plans to return the majority of proceeds from the sale to shareholders through a share buyback.
The FTC provided provisional approval of Danaher's purchase of MDS Analytical Technologies. However, it is requiring MDS to sell its laser microdissection business to Life Technologies to alleviate the agency's competition concerns.